
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Hypothesis |
Cancer Prevention Research Program [Y. Y., J. D. P., M. D. W.], and Epidemiology Program [J. L. S., M. A. R., J. D.], Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024; and Department of Pathology, University of Washington, Seattle, Washington 98103 [M. B.]
Parallel to its established causal association with both infectious
mononucleosis (IM) and young adulthood Hodgkin disease (YAHD), we
propose a hypothesis that "delayed" primary EBV infection
(i.e., primary infection occurring during adolescence or
adulthood) is associated with elevated breast cancer risk. We evaluated
this hypothesis with two investigations, one descriptive and the other
analytic. The descriptive study used international/United States cancer
registry data to assess the association between incidence rates of
breast cancer and those of YAHD. The incidence rates of the seemingly
unrelated neoplasms were strongly correlated (correlation coefficients
of 0.74 and 0.88 for international and United States data,
respectively; these were higher than the correlation coefficients of
YAHD with two other cancers that we considered). Populations with
higher incidence rates corresponded to those with higher likelihood of
delayed primary EBV infection. The analytical study was based on a
population-based case-control study of breast cancer in middle-aged
women. Age-adjusted odds ratios of breast cancer in women who reported
a history of IM, relative to women who did not, increased monotonically
from 0.55 [95% confidence interval (CI), 0.056.17] for women with
09 years of age at IM onset to 2.67 (CI, 1.046.89) for women
with
25 years of age at IM onset (P = 0.016). An
older age at tonsillectomy, another surrogate of delayed EBV exposure,
was also associated with increased risk of breast cancer: odds ratios,
0.92 (CI, 0.571.48) and 1.76 (CI, 1.152.69) for women with
tonsillectomy at 04 years of age and
15 years of age, respectively
(P = 0.018). Adjusting for additional potential
confounders did not modify the associations appreciably. The
implications of the findings and a potential biological mechanism are
presented.
This article has been cited by other articles:
![]() |
A. R Dabney and J. C Wakefield Issues in the mapping of two diseases Statistical Methods in Medical Research, February 1, 2005; 14(1): 83 - 112. [Abstract] [PDF] |
||||
![]() |
S. L. Glaser, J. L. Hsu, and M. L. Gulley Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 688 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Krieger, E. F. Strong, C. Makosky, and J. Weuve Breast Cancer, Birth Cohorts, and Epstein-Barr Virus: Methodological Issues in Exploring the "Hygiene Hypothesis" in Relation to Breast Cancer, Hodgkin's Disease, and Stomach Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 405 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Murray, D. Lissauer, J. Junying, G. Davies, S. Moore, A. Bell, J. Timms, D. Rowlands, C. McConkey, G. M. Reynolds, et al. Reactivity with A Monoclonal Antibody to Epstein-Barr Virus (EBV) Nuclear Antigen 1 Defines a Subset of Aggressive Breast Cancers in the Absence of the EBV Genome Cancer Res., May 1, 2003; 63(9): 2338 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Glaser Correspondence re: Yasui et al., Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection. 10: 9-16, 2001 Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 73 - 73. [Full Text] [PDF] |
||||
![]() |
Y. Yasui and J. D. Potter Reply Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 74 - 74. [Full Text] [PDF] |
||||
![]() |
L. Titus-Ernstoff, K. M. Egan, P. A. Newcomb, J. Ding, A. Trentham-Dietz, E. R. Greenberg, J. A. Baron, D. Trichopoulos, and W. C. Willett Early Life Factors in Relation to Breast Cancer Risk in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., February 1, 2002; 11(2): 207 - 210. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |